Facebook
Twitter
LinkedIn
Forward
Department of Pediatrics Research Week 2024
The Department of Pediatrics’ annual Research Week will be held virtually May 13-17, 2024. Through a mix of live-streamed lectures, in-person events and interactive sessions, members of the Department of Pediatrics and the entire University of Wisconsin–Madison community can hear the latest advances in pediatric research.
Activities for the week include small group sessions with faculty and trainees, Fellows' Capstone Presentations, the distinguished Gerard B. Odell Lecture, the Wald Faculty Research Forum and Town Hall, Keynote Lecture, platform presentations, and an in-person poster session with reception featuring the research of residents, fellows, faculty, and staff.
Intended Audience
The intended audience for this activity is physicians, nurses, researchers, and students in the Department of Pediatrics who participate in research activities.
Learning Objectives
By participating in the is activity, members of the healthcare team will be able to:
- Discuss mechanisms for incorporating scholarly research into one's own research projects
- Identify best practices for developing Mentor and Mentee relationships to enhance and grow research projects across disciplines
- Demonstrate how QI initiatives and research directly impact health care disparities and patient outcomes
- Collaborate with faculty, staff, and trainees across disciplines to identify best practices in research
- Examine best practices for including diversity, equity and inclusion standards into scholarly work and research projects
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient Care and Procedural Skills, Systems-based Practice
- National Academy of Medicine (NAM)/Nursing: Employ Evidence-based Practice
- Interprofessional Education Collaborative Competencies: Values and Ethics, Roles and Responsibilities, Interprofessional Communication
- Diversity, Equity, and Inclusion: Address Health Disparities, Value Diversity in the Clinical Encounter
| Monday, May 13 | |
|---|---|
| 8:00 am - 9:00 am Zoom | Combating Racial Inequities in Maternal and Infant Mortality
|
| 12:00 pm - 1:00 pm Zoom | Examining the Blurry Line Between Quality Improvement and Research
Project HIFLO: Decreasing Use of High-flow Nasal Cannula in Mild-moderate Bronchiolitis
|
| Tuesday, May 14 | |
| 8:00 am - 9:00 am Zoom | Collaborating with the Institute for Clinical and Translational Research to Extend your Research
|
| 12:00 pm - 1:00 pm Zoom | Adolescent Perspectives on Research Participation No CE Credit for this session |
| Wednesday, May 15 | |
| 8:00 am - 9:00 am Zoom | A Panel Discussion on Engaging Learners in Scholarly Work
|
| 1:30 pm - 5:15 pm Hybrid | Fellow Capstone Research Presentations
|
| Thursday, May 16 | |
| 7:30 am - 8:30 am Hybrid | Grand Rounds *CE offered through RSS Stephen Meyn, MD, PhD |
| 8:30 am - 9:00 am Hybrid | Odell Award Presentation
|
| 9:30 am - 10:00 am Hybrid | Research Updates Becky Bound |
| 10:00 am Hybrid | Ellen Wald Faculty Research Forum and Town Hall Growing Little PEAPODs A look at Rhinovirus Circulation patterns in Children Predicting Neurological Deterioration in the Pediatric ICU Family LENS: Lived Experience in Scholarship related to Children with Medical Complexity
|
| Friday, May 17 | |
| 8:00 am - 9: 00 am Zoom | Pediatric Surgical Research: Elevating Care Beyond UW
|
| 1:00 pm - 1:30 pm Hybrid | Reflections on an Unexpected Career in Global Health Research Tony Garcia-Prats, MD, MSc, PhD |
| 1:30 pm - 3:00 pm Hybrid | Platform Presentations
Effectiveness of Intratracheal Surfactant and Budesonide for Prevention of Bronchopulmonary Dysplasia Band-Aids Don't Fix Bullet Holes: The Impact of State Legislation on Pediatric Firearm Injury Mortality 2010 through 2021 Discovery Urinary Metabolomics of Preterm Neonatal Acute Kidney Injury Adolescents’ Experiences with Cyberbullying on TikTok are Associated with Depression An In-vitro Monocyte Model for Investigating the Role of Immune Dysfunction in Cystic Fibrosis Disease Onset and Progression A Quality Improvement Project to Reduce Magnetic Resonance Imaging Sedation in Children |
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/ Unapproved uses of drugs/devices in presentation? |
Bernadette Gillick, PhD, MSPT, PT | Course Director | No relevant financial relationships with ineligible companies to disclose | No |
Michelle Kelly, MD, PhD | Course Director | Invenra (Stock) | No |
Miguel Garcia | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Jim Gern, MD | Planner | Via Nova Therapeutics, Inc. (Independent Contractor - Consultant), MeissaVaccines Inc. (Independent Contractor - Consultant), Arrowhead Pharmaceuticals, Inc. (Independent Contractor - Consultant) | No |
Emily Ruedinger, MD, MED | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Mala Mathur, MD, MPH | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Dan Sklansky, MD | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Doug Dean III, PhD | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Tyler Sternhagen, MD | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Emily Schumacher, DNP, RN, CPNP | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Ellen Selkie, MD, PhD | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Kristin Shadman, MD | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Narmin Mukhtarova, MD | Planner | No relevant financial relationships with ineligible companies to disclose | Yes |
Rebecca Bound | Planner | No relevant financial relationships with ineligible companies to disclose | No |
Jasmine Zapata, MD, MPH | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Allie Hurst, MD, MS | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Elizabeth Burnside, MD, MPH, MS, FACR | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Allan Brasier | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Hannah Waldman | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Paige Condit, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Erin Kelleher, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Haroon Ali, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Zachary Gray, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Zachary Smith, DO | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Joe Presson, DO | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Doha Hassan, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Adam Cordum, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Sarah Trinh, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Katie Voelz, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Jesse Boyett Anderson, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Bryan Vonasek, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Bryn Webb, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Whitley Hulse, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Neil Munjal, MD MS | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Jo Wilson, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Heidi Kloster, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Walid A. Farhat, MD, FACS, GPLLM | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Anthony Garcia-Prats, MD, MSc, PhD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Amber McKenna, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Adnan Ahmad, DO | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Chelsea Olson, PhD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Hara Levy, MD, MMSc | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Juan Boriosi, MD | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
Danielle Gerber | Faculty | No relevant financial relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
 | Accreditation Statement In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 14.25 ANCC contact hours.
Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.425 CEUs or 14.25 hours. | |
Available Credit
- 14.25 AMA PRA Category 1 Credit™
- 14.25 ANCC Contact Hours
- 14.25 University of Wisconsin–Madison Continuing Education Hours
- 14.25 Approved for AMA PRA Category 1 Credit™